There are 2789 resources available
1180P - Anlotinib combined with radiotherapy in locally advanced non-small cell lung cancer (LANSCLC): A prospective, single-arm, phase II study
Presenter: Peng Ning
Session: ePoster Display
1181P - The impact of dosimetric parameters on pneumonitis in patients with stage III non-small cell lung cancer during maintenance treatment with durvalumab after chemoradiotherapy
Presenter: Martina Vrankar
Session: ePoster Display
1244P - Real-world EGFR and T790M testing patterns in patients from Central Eastern Europe with advanced non-small cell lung cancer: Results from a large retrospective study (REFLECT)
Presenter: Mircea Dediu
Session: ePoster Display
1291P - A phase II study of nivolumab rechallenge therapy in advanced NSCLC patients who responded to prior anti-PD-1/L1 inhibitors: West Japan Oncology Group 9616L
Presenter: Shunsuke Teraoka
Session: ePoster Display
1186P - Study on possible mechanisms of HPD associated with the amplification of chromosome 11q13 in NSCLC
Presenter: Jie Lei
Session: ePoster Display
1187P - A mutation characteristics analysis of SMARCA4defSMARCA2wt in lung cancer
Presenter: Jisheng Li
Session: ePoster Display
1294P - 18F-FDG PET-TC derived parameters as a tool to select pembrolizumab single agent or in combination with chemotherapy in first-line NSCLC
Presenter: Filippo Dall'Olio
Session: ePoster Display
1137P - Machine learning radiomics for prediction of survival in non-small cell lung cancer patients studied with PET/CT and FDG
Presenter: Andrea Ciarmiello
Session: ePoster Display
1139P - Carcinoma of unknown primary (CUP): The role of tumor genomic profiling
Presenter: Cathleen Park
Session: ePoster Display